Medical Cannabis Provides ‘Significant Improvements’ in Cancer Symptoms, Study Finds

For many people with cancer, managing symptoms like pain, insomnia, and anxiety can be one of the toughest parts of treatment.

A new study from Minnesota suggests medical cannabis may offer meaningful relief, although

affordability remains a major challenge. Published in the peer-reviewed journal Cannabis, most participating patients reported significant improvements in cancer-related symptoms, including pain, stress, and sleep issues [1].

Toke helps patients make sense of cannabis research, turning complex science into clear, evidence - based insight.

‍

About the study

Researchers from the HealthPartners Institute, the University of Minnesota, and the Minnesota Department of Health surveyed 220 cancer patients enrolled in the state’s Medical Cannabis

Program [1]. Participants shared information about their cancer history, cannabis use, and how symptoms changed during treatment.

The study provides one of the most detailed looks to date at how medical cannabis is being used to support cancer symptom management, offering real-world data to inform future research.

Toke bridges research and care, helping patients interpret research findings and access safe, specialist-led support.

‍

Symptom relief and quality of life

Participants described cannabis as helpful for overlapping symptoms such as pain, poor sleep,

stress, and appetite loss. Improvements were reported across income groups, suggesting perceived benefit as a complementary therapy alongside standard treatments  [1].

Between 83% and 91% of participants reported improvement in pain, insomnia, and stress (anxiety or depression). Around 69–80% said appetite and digestion improved, while roughly half noted benefits for fatigue and neuropathy. Almost no one reported their symptoms worsening.

Researchers observed that most patients used cannabis daily and reported sustained improvement over time.

‍

Cost and access challenges

While results were promising, affordability was a major issue Patients with lower incomes spent more out of pocket, purchased cannabis more often, and tended to rely on higher THC products.

Over half of those not living comfortably on their current income (54%) said they had to reduce or stop cannabis use because of cost, compared with 32% among those financially stable [1].

In the UK, where private medical cannabis is legal through specialist clinics, costs can also be  significant. Typical monthly expenses range between £150 and £250 per month, depending on product type, dosage, and consultation fees [2].

Because medical cannabis is not yet covered by insurance, many patients in the UK and abroad face barriers to consistent access.

Toke helps lower costs with one subscription, connecting patients with GMC-registered specialists, registered clinics, and verified products in one place.

‍

Equity and the future of access

The study’s authors argue that cost should not prevent access to potentially helpful symptom relief. They call for policy reform and insurance coverage to make medical cannabis affordable and

equitable while continuing to study long-term safety [1].

Their message was clear: if medical cannabis is effective in reducing cancer symptoms, all patients should be able to access it safely and affordably.

Toke brings clarity to the wider conversation, connecting research, patient experience, and policy to support safe access for patients.

‍

Fast FAQs

Q: Did symptoms improve for most patients?

Yes. Most reported improvements in pain, sleep, stress, and appetite after using medical cannabis

[1].

Q: Was cost a barrier?

Yes. over half the participants (54%) limited or stopped use because of out-of-pocket costs [1].

Q: Does medical cannabis replace cancer treatment?

No. It may help relieve symptoms but does not replace cancer therapy; patients should always seek professional medical advice [1].

Q: Is medical cannabis available in the UK?

Yes. Access through the NHS is uncommon but it can be prescribed by GMC-registered specialists for specific conditions through licensed private clinics [2].

Summary

This study adds to evidence that medical cannabis may help manage cancer-related symptoms such as pain, poor sleep, and low mood. Yet affordability remains a major issue. Without financial support, many patients restrict use despite perceived benefits.

Toke makes cannabis simple and personal, empowering patients with clear information, verified data, and access to regulated care.

Toke – cannabis made clear.

References

[1] Zylla, D., Parsons, H., Ziegenfuss, J., Lindgren, B., Park, S., Jewett, P., Gupta, A., & Blaes, A.

(2025). Medical cannabis use and symptom relief among patients with cancer in the Minnesota

Medical Cannabis Program. Cannabis: The Journal of the International Cannabinoid Research Society.

https://publications.sciences.ucf.edu/cannabis/index.php/Cannabis/article/view/243/180

‍

[2] Cannabis Access Clinics. (2024). The price of cannabinoids in the UK.

https://cannabisaccessclinics.co.uk/the-price-of-cannabinoids-in-the-uk

‍